Haemonetics(DE:HAZ)
€109.00+2.00 (+1.87%)
DE:HAZ
Haemonetics ownership
€109.00
At close:+2.00 (+1.87%)
Haemonetics (HAZ) Ownership - Who Owns Haemonetics?
1 Followers
Haemonetics (HAZ) Ownership Overview
- 1.82% Insiders
- 38.74% Mutual Funds
- 27.10% Other Institutional Investors
- 28.96% ETFs
- 3.37% Public Companies and Individual Investors
The ownership structure of Haemonetics (DE:HAZ) stock is a mix of institutional, retail, and individual investors. Approximately 94.81% of the company’s stock is owned by Institutional Investors, 1.82% is owned by Insiders, and 3.37% is owned by Public Companies and Individual Investors.
The ownership structure of Haemonetics (DE:HAZ) stock is a mix of institutional, retail, and individual investors. Approximately 94.81% of the company’s stock is owned by Institutional Investors, 1.82% is owned by Insiders, and 3.37% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Nov 12, 2026 | Farris Maryanne Maunsell | $101,148 | |
| Nov 11, 2025 | Mark Kroll | $98,784 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Royce & Associates Llc | €5,728,721 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| BlackRock, Inc. | 5,953,537 | Institution | 13.07% | 715,353,192 |
| Ishares | 5,373,005 | Institution | 11.80% | 645,598,789 |
| Vanguard | 4,259,197 | Institution | 9.35% | 511,768,075 |
| Neuberger Berman Equity Funds | 3,667,859 | Institution | 8.05% | 440,715,266 |
| Vanguard Index Funds | 3,645,248 | Institution | 8.00% | 437,998,419 |
| John Rogers | 2,173,575 | Institution | 4.77% | 261,168,078 |
| Spdr | 1,106,660 | Institution | 2.43% | 132,971,839 |
| Ariel Investment Trust | 769,475 | Institution | 1.69% | 92,457,038 |
| Dfa Investment Dimensions Group Inc | 679,577 | Institution | 1.49% | 81,655,254 |
| Touchstone Strategic Trust | 614,824 | Institution | 1.35% | 73,874,793 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Neuberger Berman Equity Funds | 3,667,859 | Institution | 8.05% | 440,715,266 |
| Vanguard Index Funds | 3,645,248 | Institution | 8.00% | 437,998,419 |
| Ariel Investment Trust | 769,475 | Institution | 1.69% | 92,457,038 |
| Dfa Investment Dimensions Group Inc | 679,577 | Institution | 1.49% | 81,655,254 |
| Touchstone Strategic Trust | 614,824 | Institution | 1.35% | 73,874,793 |
| Allspring Funds Trust | 587,266 | Institution | 1.29% | 70,563,533 |
| Fidelity Salem Street Trust | 567,706 | Institution | 1.25% | 68,213,282 |
| Fidelity Concord Street Trust | 526,778 | Institution | 1.16% | 63,295,537 |
| Vanguard Scottsdale Funds | 435,718 | Institution | 0.96% | 52,354,132 |
| Royce Fund | 363,531 | Institution | 0.80% | 43,680,431 |
FAQ
Who Owns Haemonetics (DE:HAZ)?
According to the latest TipRanks data, approximately 94.81% of the company's stock is held by institutional investors, 1.82% is held by insiders, and 3.37% is held by public companies and individual investors.
What percentage of Haemonetics (DE:HAZ) stock is held by institutional investors?
According to the latest TipRanks data, approximately 94.81% of Haemonetics (DE:HAZ) stock is held by institutional investors: 38.74% by mutual funds, 28.96% by ETFs and 27.10% by other institutional investors.
What percentage of Haemonetics (DE:HAZ) stock is held by retail investors?
According to the latest TipRanks data, approximately 3.37% of Haemonetics (DE:HAZ) stock is held by public companies and individual investors.
Who owns the most shares of Haemonetics (DE:HAZ)?
BlackRock, Inc. owns the most shares of Haemonetics (DE:HAZ).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
